Identification and functional analysis of an EMT-accelerating factor induced in pancreatic cancer cells by an anticancer agent-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification and functional analysis of an EMT-accelerating factor induced in pancreatic cancer cells by an anticancer agent

Published:2016 Issue:1 Volume:31 Page:76-84
ISSN:0913-0071
Container-title:Suizo
language:en
Short-container-title:Journal of the Japan Pancreas Society

Author:

SHIMASAKI Takeo¹²³,YAMAMOTO Satoko¹,ISHIGAKI Yasuhito¹,TAKATA Takanobu¹,ARISAWA Tomiyasu³,MOTOO Yoshiharu⁴,TOMOSUGI Naohisa¹²,MINAMOTO Toshinari⁵

Affiliation:

1. Medical Research Institute, Kanazawa Medical University

2. Project Research Center, Kanazawa Medical University

3. Department of Gastroenterology, Kanazawa Medical University

4. Department of Medical Oncology, Kanazawa Medical University

5. Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University

Publisher

Japan Pancreas Society

Link

https://www.jstage.jst.go.jp/article/suizo/31/1/31_76/_pdf

Reference29 articles.

1. 1) Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2015; 45: 884-91.

2. 2) Wada K, Takaori K, Traverso LW, et al. Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012. J Hepato-biliary-pancreatic Sci 2013; 20: 557-66.

3. 3) Egawa S, Toma H, Ohigashi H, et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 2012; 41: 985-92.

4. 4) Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007; 25: 1960-6.

5. 5) Berlin JD, Catalano P, Thomas JP, et al. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. J Clin Oncol 2002; 20: 3270-5.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion;World Journal of Gastroenterology;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3